{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T04:40:05Z","timestamp":1768624805031,"version":"3.49.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T00:00:00Z","timestamp":1573516800000},"content-version":"vor","delay-in-days":2141,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"the"},{"name":"Dietmar Hopp Foundation","award":["DHS05\/2006"],"award-info":[{"award-number":["DHS05\/2006"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1093\/annonc\/mdt509","type":"journal-article","created":{"date-parts":[[2013,12,19]],"date-time":"2013-12-19T14:41:03Z","timestamp":1387464063000},"page":"189-195","source":"Crossref","is-referenced-by-count":69,"title":["Autologous stem cell transplantation for elderly patients with newly diagnosed multiple myeloma in the era of novel agents"],"prefix":"10.1016","volume":"25","author":[{"given":"M.","family":"Merz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Neben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.S.","family":"Raab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Sauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Egerer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Hundemer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Hose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Kunz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Hei\u00df","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.D.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Goldschmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Hillengass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdt509_bb0010","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1182\/asheducation.V2012.1.335.3792205","article-title":"Have drug combinations supplanted stem cell transplantation in myeloma?","volume":"2012","author":"Palumbo","year":"2012","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"Suppl 7","key":"10.1093\/annonc\/mdt509_bb0015","doi-asserted-by":"crossref","first-page":"vii128","DOI":"10.1093\/annonc\/mdn449","article-title":"Autologous transplantation for multiple myeloma","volume":"19","author":"Harousseau","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdt509_bb0020","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/sj.bmt.1705486","article-title":"Autologous transplantation in elderly patients with multiple myeloma: are we asking the right questions?","volume":"38","author":"Klepin","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1093\/annonc\/mdt509_bb0025","doi-asserted-by":"crossref","first-page":"6063","DOI":"10.1182\/blood-2011-02-297325","article-title":"International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation","volume":"117","author":"Cavo","year":"2011","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdt509_bb0030","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S0140-6736(07)61537-2","article-title":"Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99\u201306): a randomised trial","volume":"370","author":"Facon","year":"2007","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdt509_bb0035","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1182\/blood.V94.4.1248","article-title":"Dose-intensive melphalan with stem cell support (MEL100) is superior to standard treatment in elderly myeloma patients","volume":"94","author":"Palumbo","year":"1999","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdt509_bb0040","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1200\/JCO.2009.22.7561","article-title":"Bortezomib as induction before autologous transplantation, followed by lenalidomide as consolidation-maintenance in untreated multiple myeloma patients","volume":"28","author":"Palumbo","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdt509_bb0045","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/sj.thj.6200312","article-title":"Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation","volume":"4","author":"Durie","year":"2003","journal-title":"Hematol J"},{"key":"10.1093\/annonc\/mdt509_bb0050","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","article-title":"International staging system for multiple myeloma","volume":"23","author":"Greipp","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdt509_bb0055","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1182\/blood-2011-09-379164","article-title":"Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17p","volume":"119","author":"Neben","year":"2012","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdt509_bb0060","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/sj.leu.2404284","article-title":"International uniform response criteria for multiple myeloma","volume":"20","author":"Durie","year":"2006","journal-title":"Leukemia"},{"key":"10.1093\/annonc\/mdt509_bb0065","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1200\/JCO.2011.39.6820","article-title":"Bortezomib induction and maintenance treatment in patients with newly diagnosed","volume":"30","author":"Sonneveld","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdt509_bb0070","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.3324\/haematol.2009.016436","article-title":"Combining information regarding chromosomal aberrations t(4;14) and del(17p13) with the International Staging System classification allows stratification of myeloma patients undergoing autologous stem cell transplantation","volume":"95","author":"Neben","year":"2010","journal-title":"Haematologica"},{"key":"10.1093\/annonc\/mdt509_bb0075","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1046\/j.1365-2141.2001.02976.x","article-title":"Autologous stem cell transplantation in elderly multiple myeloma patients over the age of 70 years","volume":"114","author":"Badros","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1093\/annonc\/mdt509_bb0080","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/sj.bmt.1702188","article-title":"The role of autologous transplantation in patients with multiple myeloma aged 65 years and over","volume":"25","author":"Sirohi","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1093\/annonc\/mdt509_bb0085","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1182\/blood.V93.1.51","article-title":"Age is not a prognostic variable with autotransplants for multiple myeloma","volume":"93","author":"Siegel","year":"1999","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdt509_bb0090","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/sj.bmt.1705360","article-title":"High-dose melphalan (200 mg\/m2) supported by autologous stem cell transplantation is safe and effective in elderly (>or=65 years) myeloma patients: comparison with younger patients treated on the same protocol","volume":"37","author":"Jantunen","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1093\/annonc\/mdt509_bb0095","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/sj.bmt.1705580","article-title":"Autologous stem cell transplantation is safe and feasible in elderly patients with multiple myeloma","volume":"39","author":"Qazilbash","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1093\/annonc\/mdt509_bb0100","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1182\/blood-2011-11-374249","article-title":"IMWG Consensus on maintenance therapy in multiple myeloma","volume":"119","author":"Ludwig","year":"2012","journal-title":"Blood"},{"issue":"Suppl 7","key":"10.1093\/annonc\/mdt509_bb0105","doi-asserted-by":"crossref","first-page":"vii117","DOI":"10.1093\/annonc\/mdn437","article-title":"Prognostic factors for multiple myeloma in the era of novel agents","volume":"19","author":"Blade","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdt509_bb0110","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1200\/JCO.2012.46.2598","article-title":"Chromosomal abnormalities are major prognostic factors in elderly patients with","volume":"31","author":"Avet-Loiseau","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdt509_bb0115","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3324\/haematol.2012.075051","article-title":"Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials","volume":"98","author":"Bringhen","year":"2013","journal-title":"Haematologica"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419359629?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419359629?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/25\/1\/189\/16701404\/mdt509.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T07:29:10Z","timestamp":1624519750000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419359629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0923753419359629"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdt509","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}